The STEP trials, which followed over 4,500 participants, reported depression in fewer than 2% of semaglutide usersa rate similar to placebo groups
Medical board and malpractice exposure, an honest assessment In a board investigation or malpractice claim, the file you can produce matters more than the evidence base behind the compound
At the end of the 12-week intensive lifestyle intervention lead-in period, 579 patients who achieved 5% weight reduction were randomized in a 1:1 ratio to ZEPBOUND or placebo for 72 weeks
The serious adverse event profile appears broadly similar to other incretin-based therapies, but with the addition of glucagon-related effects
This finding supports the potential clinical utility of lactate in ischemic stroke
Prolonged and protracted labor and fever can also cause telogen effluvium